| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 43.90B | 43.58B | 43.27B | 39.18B | 35.13B | 39.15B |
| Gross Profit | 6.66B | 6.66B | 6.63B | 5.07B | 2.17B | 890.00M |
| EBITDA | 3.94B | 3.50B | 3.48B | 3.89B | 866.00M | -1.29B |
| Net Income | 2.04B | 2.21B | 1.95B | 1.69B | -1.25B | -3.16B |
Balance Sheet | ||||||
| Total Assets | 33.03B | 32.75B | 33.15B | 31.37B | 31.41B | 34.86B |
| Cash, Cash Equivalents and Short-Term Investments | 1.46B | 1.31B | 1.43B | 1.11B | 1.04B | 1.07B |
| Total Debt | 9.40B | 11.65B | 13.66B | 13.48B | 15.48B | 17.17B |
| Total Liabilities | 21.79B | 22.21B | 24.78B | 25.23B | 27.04B | 28.80B |
| Stockholders Equity | 11.12B | 10.45B | 8.32B | 6.07B | 4.22B | 5.74B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.16B | 937.00M | 870.00M | -517.00M | -1.93B |
| Operating Cash Flow | 0.00 | 2.92B | 1.57B | 1.31B | -29.00M | -1.31B |
| Investing Cash Flow | 0.00 | -89.00M | -597.00M | 815.00M | 1.76B | 932.00M |
| Financing Cash Flow | 0.00 | -2.88B | -657.00M | -2.12B | -1.77B | 780.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥16.08B | 13.38 | ― | 2.53% | -1.20% | -8.71% | |
77 Outperform | ¥18.55B | 17.75 | ― | 2.49% | 3.18% | -21.69% | |
76 Outperform | ¥14.36B | 15.76 | ― | 2.65% | 7.89% | -12.90% | |
75 Outperform | ¥9.39B | 13.41 | ― | 1.83% | 10.06% | 4.96% | |
73 Outperform | ¥19.81B | 18.27 | ― | 2.14% | 6.21% | ― | |
63 Neutral | ¥11.98B | 5.85 | ― | 1.74% | 0.30% | -14.49% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |